It has been discovered through epidemiological studies that there is a relationship between type II diabetes (NIDDM), human insulin- or insulin analog-based diabetes treatment, and the development of some cancers such as breast, pancreas, colon, and rectum, as well as kidney [13,14,15,16,17,18,19,20]. This evidence concerns the gene INS and type 2 diabetes mellitus.